These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [TBL] [Abstract][Full Text] [Related]
44. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602 [TBL] [Abstract][Full Text] [Related]
45. [The experience of the Bordeaux blood transfusion center in the detection of the Australia antigen]. Mesnier F; Traissac FJ; Dubarry JJ; Quinton A Arch Fr Mal App Dig; 1971 Dec; 60(12):648-9. PubMed ID: 5158154 [No Abstract] [Full Text] [Related]
46. Screening blood for viral genomes: which way to go? Allain JP Transfus Med; 1998 Mar; 8(1):5-7. PubMed ID: 9569452 [No Abstract] [Full Text] [Related]
47. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315 [TBL] [Abstract][Full Text] [Related]
48. Hepatitis B virus infection and transfusion medicine: science and the occult. Hollinger FB Transfusion; 2008 May; 48(5):1001-26. PubMed ID: 18454738 [No Abstract] [Full Text] [Related]
49. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ; Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [TBL] [Abstract][Full Text] [Related]
50. [The White Book]. Rouger P Transfus Clin Biol; 2008 Nov; 15(5):314-7. PubMed ID: 18922721 [TBL] [Abstract][Full Text] [Related]
51. Reacting to an emerging safety threat: West Nile virus in North America. Stramer SL Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880 [TBL] [Abstract][Full Text] [Related]
52. The utility of multiplex NAT in blood screening. Candotti D; Allain JP Dev Biol (Basel); 2007; 127():71-86. PubMed ID: 17486882 [No Abstract] [Full Text] [Related]
53. Genomic screening for blood-borne viruses in transfusion settings. Lee HH; Allain JP Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433 [No Abstract] [Full Text] [Related]
54. Situation of the blood banks in the region of the Americas, 1994-1995. Epidemiol Bull; 1997 Mar; 18(1):11-2. PubMed ID: 9197084 [No Abstract] [Full Text] [Related]
55. Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing. Ferschke J J Clin Apher; 2008; 23(6):191-5. PubMed ID: 18973114 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D; Chevaliez S; Pawlotsky JM Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [TBL] [Abstract][Full Text] [Related]
57. Proper donor screening--a good prevention of transfusion transmitted AIDS and hepatitis. Chatterjee K J Acad Hosp Adm; 1994 Jul; 6(2):49-52. PubMed ID: 10537998 [No Abstract] [Full Text] [Related]
58. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Cable R; Musavi F; Notari E; Zou S; Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796 [TBL] [Abstract][Full Text] [Related]
59. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV; Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818 [TBL] [Abstract][Full Text] [Related]
60. Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population. Tseliou PM; Spiliotakara A; Politis C; Spanakis N; Legakis NJ; Tsakris A Transfus Med; 2004 Jun; 14(3):253-4. PubMed ID: 15180821 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]